8-KThe WireRoutine
Shareholder Vote
Filed May 19, 2022 · 4y ago · Accession 0001193125-22-155023
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Kalaris Therapeutics, Inc.
- Ticker
- KLRS
- CIK
- 1754068
- Form type
- 8-K
- Filing date
- May 19, 2022
- Report date
- May 17, 2022
- Document
- d346922d8k.htm
- Size
- 153 KB